Browsing Tag
Sunnybrook Health Sciences Centre
2 posts
FDA opens first human test for BriaCell’s prostate cancer cell therapy
Bria-PROS+ gains FDA clearance for its first prostate cancer trial, expanding BriaCell’s off-the-shelf cellular immunotherapy platform.
Canada has the science. Sunnybrook’s $41m bet asks if it has the trial infrastructure
Canada has research strength but trial bottlenecks. Sunnybrook’s $41M gift may change how therapies reach patients faster.